Medroxyprogesterone acetate (MPA), also known as depot medroxyprogesterone acetate (DMPA) in injectable form and sold under the brand name Depo-Provera among others, is a hormonal medication of the progestin type.

2024年9月26日 · Depot medroxyprogesterone acetate (DMPA, also known as DepoProvera) is an injectable progestin-only contraceptive that provides highly effective, private, three-month-long reversible contraception. Use of DMPA eliminates the need for daily user action, action near the time of sexual intercourse, and need for partner cooperation.

Unexpected vaginal bleeding during therapy with MPA should be investigated. MPA may cause some degree of fluid retention, therefore, caution should be exercised in treating any patient with a pre-existing medical condition that might be adversely affected by fluid retention.

2020年11月12日 · MPA depot injection can decrease bone mineral density, possibly irreversible in postmenopausal women. Calcium and vitamin D supplementation are recommended.

Depot medroxyprogesterone acetate (DMPA) is an injectable contraceptive that has been used by approximately 1 in 5 adolescents and adult women in the United States who have had sex 1. Depot medroxyprogesterone acetate is a highly effective contraceptive that affords privacy (similar to an intrauterine system) and has a convenient dose schedule ...

Depo-Provera CI (medroxyprogesterone acetate [MPA]) inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation and causes thickening of cervical mucus. These actions contribute to its contraceptive effect.

2022年1月6日 · Injectable DMPA should be given intramuscularly 100 mg every 2 weeks for at least 6 months and DMPA can also be given intramuscularly 150 mg every 3 months in endometriosis. Medroxyprogesterone Acetate should not …

MPA in a concentration of 150 mg/ml is available for depot contraceptive use in single-dose, 1 ml vials; injection with a 21- or 23-gauge needle is appropriate. A higher concentration depot formulation (400 mg/ml) is used for the treatment of endometrial and renal cancer.

Depot medroxyprogesterone acetate (DMPA) is an aqueous suspension of 17-acetoxy 6-methyl progestin administered by intramuscular injection for long-term contraception. This highly effective injectable formulation of medroxyprogesterone acetate (MPA) has a prolonged duration of action since the proge …

Fertigspritze (1 ml) Depo-Clinovir enthält 150 mg Medroxyprogesteronacetat (MPA) in steriler wässriger Suspension. Vollständige Auflistung der sonstigen Be-standteile, siehe Abschnitt 6.1.